From: Etheno adducts: from tRNA modifications to DNA adducts and back to miscoding ribonucleotides
DNA Source | Adducts/108 nucleotides | Method | Reference | ||||
---|---|---|---|---|---|---|---|
1,N6-ε-dAdo | 3,N4-ε-dCyd | 1,N2-ε-dGuo | N2,3-ε-dGuo | ||||
Rat | Liver | 0.10–0.12 | 0.10–0.12 |  |  | Immunoaffinity/32P labeling | [47] |
 | Liver |  |  |  | 18–23 | GC/MS | [47] |
 | Liver | 120 | 560 |  |  | HPLC/32P labeling | [62] |
 | Liver | 0.011–0.012 | 0.016–0.017 |  |  | Immunoaffinity/32P labeling | [63] |
 | Lung | 0.4–0.5 | 1.8–3.8 |  |  | Immunoaffinity/32P labeling | [63] |
 | Kidney | 0.7–0.8 | 2.1–2.8 |  |  | Immunoaffinity/32P labeling | [63] |
 | Lymphocytes | 1.1 | 1.2 |  |  | Immunoaffinity/32P labeling | [63] |
 | Hepatocytes |  |  |  | 1.4 | Immunoaffinity/GC/MS | [64] |
 | Hepatocytes |  |  | NDa |  | Immunoaffinity/GC/MS | [65] |
Human | Hepatocytes | Â | Â | Â | 2.0 | LC/MS | [66] |
 | Oral cells | 0.77 | 0.61 |  |  | LC/MS | [67] |
 | Placenta | 74–84 |  |  |  | LC/MS | [68] |
 | Placenta | 1.1 |  |  |  | LC/MS | [69] |
 | Pancreas | 1.8 | 1.2 |  |  | Immunoaffinity/32P labeling | [70] |